ENZON PHARMACEUTICALS

Company

Viskase Holdings, Inc.

Filed

February 11, 2008

Accession Number

0000932471-08-000169

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →